Biogen to Acquire Apellis for $5.6 billion, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease
On Mar. 31, 2026, Biogen and Apellis Pharmaceuticals announced the companies have entered into a definitive agreement under…
-
-
Biotechnology | Clinical Research | Diagnostics | Environmental | Infectious Disease | NIH | Non-Profit Research | Rare Disease | Therapeutics | Vaccine
NIH restrictions on foreign research partnerships significantly impacted 1 in 4 U.S. scientists
On Mar. 27, 2026, a STAT survey conducted of nearly 1,000 National Institutes of Health (NIH) -supported scientists,…
-
Biotechnology | Disease | FDA | Pharmaceutical | Rare Disease | Stem Cell
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
On Mar. 27, 2026, Rocket Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has granted accelerated approval…
-
Biotechnology | Cardiology | Diagnostics | FDA | Neurology | NIH | Rare Disease | Therapeutics | Women's Health
NIH invests $150 million in human-based research to reduce use of animal models
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…
-
Baby boy first child born in the UK after mother transplanted with a womb from deceased donor
On Feb. 24, 2026, Womb Transplant UK announced in an historic breakthrough, that a bouncing baby boy has…
-
Biotechnology | Clinical Research | Diagnostics | FDA | Genomics | Infectious Disease | Medical Device | Medicine | Non-Profit Research | Oncology | Ophthalmogy | Organ Transplant | Pharmaceutical | Rare Disease | Therapeutics | U.S. Congress | Vaccine | Women's Health
U.S. healthcare spending soars to over $5 trillion in 2024
On Jan. 14, 2026, U.S. healthcare spending rose by 7.2% to $5.3 trillion in 2024 from $4.9 trillion…
-
How some people get drunk from their own gut bacteria
On Jan. 8, 2026, researchers reported results from a study on the largest cohort of autobrewery syndrome (ABS)…
-
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases
On Dec. 19, 2025, BioMarin Pharmaceutical and Amicus Therapeutics announced that BioMarin has entered into a definitive agreement…
-
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | Non-Profit Research | Oncology | Rare Disease | Therapeutics
CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials
On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
-
New AI model could speed rare disease diagnosis
On Nov. 24, 2025, a new AI model called popEVE developed by Harvard Medical School researchers and colleagues…
-
Agriculture | Artificial Intelligence | Biotechnology | CRISPR | Diagnostics | Environmental | Forestry | Genomics | Infectious Disease | Marine Science | Materials | Nanotechnology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Quantum | Rare Disease | Robotics | Software | Stem Cell | Therapeutics | U.S. Congress | Uncategorized | Vaccine | Women's Health
Report Shows How University Research Spending Benefits U.S. Businesses
On Nov. 20, 2025, the Institute for Research on Innovation and Science (IRIS) released a report that demonstrates…
-
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | FDA | Genomics | HIV | Infectious Disease | Influenza | Nanotechnology | Neurology | NIH | Oncology | Organ Transplant | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
-
Arrowhead Pharma Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
On Nov. 18, 2025, Arrowhead Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved REDEMPLO…
-
Agriculture | Artificial Intelligence | Biotechnology | Chemistry | Clinical Research | Diagnostics | Energy | Environmental | Infectious Disease | Marine Science | Medical Device | Nanotechnology | Neurology | NIH | Non-Profit Research | Rare Disease | Therapeutics | Vaccine | Women's Health
NIH funding cuts have impacted more than 74,000 people enrolled in trials
On Nov. 17, 2025, a JAMA published study found that more than 74,000 people have had their lives…
-
Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push
On Oct. 15, 2025, Danish drugmaker Novo Nordisk and Omeros announced they have signed a licensing deal worth…
-
Experimental Compound Offers Potential Treatment for Rare, Often Fatal, Childhood Disease
On Jul. 9, 2025, as part of a new study, neurologists at NYU Langone Health announced they have…
-
Last Look: Critical Ebola Research from Now-Closed U.S. NIAID BSL-4 Lab
On Jun. 5, 2025, the final studies from the recently shuttered National Institute of Allergy and Infectious Diseases’…
-
Diagnostics | Disease | Infectious Disease | Medicine | Oncology | Rare Disease | Therapeutics | WHO
Global leaders reaffirm commitment to WHO with More Than US$ 170 million
On May 20, 2025, the World Health Organization (WHO) announced that world leaders pledged at least an additional…
-
Prime Medicine Announces Breakthrough Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease
On May 19, 2025, Prime Medicine announced positive initial data from the first patient dosed in its ongoing…
-
World’s first patient treated with personalized CRISPR gene editing therapy at Children’s Hospital of Philadelphia
On May 15, 2025, a team at Children’s Hospital of Philadelphia (CHOP) and Penn Medicine announced that a…
-
Biotechnology | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | Influenza | Measles | Medicine | Neurology | NIH | Oncology | Organ Transplant | Pharmaceutical | Plague | Polio | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
HHS starts layoffs of thousands of workers across its agencies
On Apr. 1, 2025, layoff notices began arriving for thousands of employees of the sprawling U.S. Department of…
-
Biotechnology | Disease | FDA | Rare Disease
FDA Approved Qfitlia™ (fitusiran), the First siRNA (RNAi Therapeutic) for the Treatment of Hemophilia A or B
On Mar. 28, 2025, the U.S. Food and Drug Administration (FDA) announced approval of Alnylam Pharmaceuticals Qfitlia™ (fitusiran),…
-
Agriculture | Artificial Intelligence | Biotechnology | CDC | Cloning | Diagnostics | HIV | Infectious Disease | Nanotechnology | Neurology | NIH | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | USDA | Vaccine | WHO | Women's Health
75% of U.S. scientists who answered Nature poll consider leaving
On Mar. 27, 2025, a Nature survey of more than 1,200 scientists, three-quarters of the total respondents are…
-
Disease | FDA | Rare Disease
Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis
On Mar. 20, 2025, Alnylam Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval of the supplemental…
-
Diagnostics | Disease | FDA | Medical Device | Non-Profit Research | Ophthalmogy | Rare Disease | Therapeutics
FDA approves ENCELTO, a first-of-its-kind eye implant that slows vision loss in rare eye disease
On Mar. 6, 2025, the U.S. Food and Drug Administration (FDA) announced the approval of ENCELTO (revakinagenetaroretcel-lwey), a…
-
St. Judes Reports Promising results from first prenatal therapy for spinal muscular atrophy
On Feb. 19, 2025, scientists at St. Jude Children’s Research Hospital report results from a promising new approach…
-
Biotechnology | Diagnostics | FDA | Medical Device | Medicine | Pharmaceutical | Rare Disease | Therapeutics
U.S. Food and Drug Administration approved 50 new therapeutics in 2024
On Jan. 14, 2025, the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) announced…
-
World-first cure for lethal skin disease achieved in landmark study
On Nov. 11, 2024, an international team of researchers has for the first time cured patients with Toxic…
-
Biotechnology | Diagnostics | Disease | Genomics | Non-Profit Research | Rare Disease | Therapeutics | Women's Health
First newborn babies tested for over 200 genetic conditions as world-leading study begins in NHS hospitals
On Oct. 3, 2024, the National Health Service England (NHS) announced that Hundreds of babies have begun to…
-
Exome sequencing of more than 54,000 individuals with epilepsy revealed genetic links
On Oct. 3, 2024, scientists announced the largest whole-exome sequencing study of epilepsy to date, with more than…
